Monday ،Sep 23, 2019، 21:06

Pain reliever and enzyme inhibitor enter the market, MPO's Managing Director said in an interview with IRNA News Agency

Pain reliever and enzyme inhibitor enter the market, MPO's Managing Director said in an interview with IRNA News Agency
Tehran- IRNA- Three types of medicines including Opium Tincture syrup (opioid pain killer),1mg and 5mg Finasteride tablets (Enzyme inhibitor, Alpha-reductase) have been offered to the market by Soha Pharmaceutical Company which is affiliated to the Medical Procurement Organization, MPO's Managing Director announced.

In an interview with IRNA's social correspondent, Dr. Ali Faraji added that: "The medicines include Opium Tincture syrup (a 250ml oral solution, each 5ml contains 50 grams of morphine and is used for the treatment of patients who are physiologically dependent upon opioids and cannot reduce or stop opioid use abruptly), 1mg Finasteride tablet (helps to prevent hair loss in men with androgenetic alopecia pattern), and 5mg Finasteride tablet (for the treatment and control of benign prostatic hyperplasia), which have been produced and brought to the market by Soha Pharmaceutical Company", reported by MPO's Public Relations and International Affairs section, citing IRNA News Agency.

Jul 29, 2019 11:59

Comments


Sender name is required
Email is required
Characters left: 500
Comment is required


Central Office  

Taleghani St

021-88803876-9